Try Platform Try Platform
Back to news & media

Affinda walks the patient long-term capital route

The Toner brothers' Affinda business is set to embark on another capital raising in the wake of its recent $15m scrip-based Pathfindr acquisition.

Read the original article →
Affinda walks the patient long-term capital route
Full article Original source ↗

This article is available from the original publisher. We’ve included the available summary below and linked to the full story at the source.